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Pyometra is a common and life-threatening disease of intact bitches caused by hormonal
inﬂuence of the uterus in combination with bacterial infection. The treatment of choice is
ovariohysterectomy, but several purely medical options are available. Common drugs used
for medical treatment in combination with antimicrobials are progesterone receptor
blockers, prostaglandins, and dopamine agonists. The aim of this study was to evaluate
long-term recovery and fertility after treatment with the progesterone receptor blocker
aglepristone in bitches with pyometra. Data from 28 bitches with pyometra, admitted to
the University Animal Hospital, Swedish University of Agricultural Sciences, during a 9-
year period, were studied retrospectively and followed up by telephone interviews with
the owners. The bitches had been treated with aglepristone at a dose of 10 mg/kg on a
median of four occasions. All bitches had also been treated with antimicrobial drugs for a
mean duration of 23 days, the most frequently used being enroﬂoxacin. Escherichia coli
were the most commonly isolated bacteria from cranial vagina. The outcome was assessed
for up to 6 years after treatment. The success rate, determined as restored clinically healthy
status, was 75% (21/28 bitches), and the recurrence rate of disease was 48% (10/21 bitches).
The mean time until recurrence was 10.5 months after the end of treatment. After treat-
ment, 69% (9/13) of the mated bitches produced puppies. Of the seven bitches that did not
have a successful treatment, six were ovariohysterectomized and one was euthanized. In
conclusion, medical treatment with aglepristone in combination with antimicrobial ther-
apy was successful in 75% of the bitches studied and the recurrence rate was 48%.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.1. Introduction
On average, 19% of all insured Swedish bitches are diag-
nosedwithpyometra before the ageof 10years [1]. In Sweden,
thedogpopulation ismainly intact [2],which iswhypyometra
is a frequent disorder in comparison to the situation in coun-
tries where most bitches are spayed [3]. The pathogenesis of
pyometra is not fully understood, but the inﬂuenceof estrogen
followed by subsequent progesterone stimulation during a
long period of time (metoestrus) [4], in combination withC-ND license (http://
þ46 18 673435.
an).
s. Published by Elsevier Inc.
1bacterial infection, is believed to cause the disease. The bac-
teria originate from the normal ﬂora of each bitch, and (E. coli)
is the most common isolate from the uterus [5–9].
Ovariohysterectomy is the treatment of choice for pyo-
metra and is considered to be safe and effective [10]. To
maintain fertility or if surgery or anesthesia is to be avoi-
ded, several medical treatment alternatives are available.
Examples of drugs that can be used for medical treatment
of pyometra include progesterone–receptor antagonists
(aglepristone and mifepristone), prostaglandins (dinoprost
and cloprostenol), dopamine agonists (cabergoline), or
different combinations of these drugs [11–15]. Few studies
have evaluated the long-term outcome after medical
treatment, and for aglepristone, the time of follow-up
evaluation varies from after the following estrus [16,17],All rights reserved.
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treatment for a few bitches [13]. In one of the studies, the
authors maintained contact with three successfully treated
bitches for up to 6 years after treatment [19]. Although
medical treatment of pyometra has been described previ-
ously in several studies, most studies contain a limited
number of bitches, and so far there is no large study
combining all the results of the available studies. Therefore
each individual dog that is treated and the results reported
still contribute to the current mass of knowledge of which
bitches to select for this type of treatment (medical as
opposed to surgical). In Sweden, medical treatment is
rarely performed and is performed only when the general
condition of the bitch is mildly or moderately affected. This
situation differs from in other countries where medical
treatment is used for severely affected bitches including
those with peritonitis (F. Fieni, presentation, 16th EVSSAR
congress, Toulouse, France, 2013). It is plausible that the
success rate would be higher if only less severely affected
bitches are selected for medical treatment. Treatment
outcome may also differ depending on varying antimicro-
bial resistance in different countries, but few studies focus
on the choice of antimicrobial drugs used as adjunctive
treatment of pyometra [6,8]. Until now, the overall
outcome after aglepristone treatment of pyometra in
Sweden has not been studied.
The aim of this study was to investigate the long-term
outcome, that is, clinical recovery and fertility, after medi-
cal treatment with aglepristone in bitches with pyometra
in Sweden.
2. Materials and methods
2.1. Study design and animals
A retrospective study was performed at the Department
of Clinical Sciences, Swedish University of Agricultural
Sciences, Uppsala, Sweden, using data on bitches with
pyometra admitted to the University Animal Hospital
(UDS), Swedish University of Agricultural Sciences, that
were medically treated with aglepristone (Alizin vet, Vir-
bac, Stockholm, Sweden). Data were collected from all
medically treated bitches diagnosed with pyometra from
the time when aglepristone was registered for this purpose
in Sweden from June 2004 until February 2013.
2.2. Data collection
The data system of UDS was used to identify bitches
with the diagnostic code for pyometra (n ¼ 33) combined
with aglepristone. One bitch was excluded because it was
destined for surgical treatment and treated with aglepri-
stone for 1 day (stabilized before surgery). Four bitches
were excluded due to simultaneous treatment with PGF2a
or oxytocin.
All owners were interviewed by telephone by the ﬁrst
author (LR) from September to October 2013 to retrieve in-
formation of subsequent history, fertility, and long-term
outcome. For more speciﬁc information about breeding, the
Swedish Kennel Club (SKK) registry was used to obtain the
exact dates of parturition and number of registered puppies.The ﬁrst day a bitch was treated with aglepristone is in
this study was referred to as “Day 1.” Any previous days are
referred to as “Day –1,” “Day –2,” and so on (i.e. there was
no Day 0).
2.3. Studied variables
Case history data were based on the owners’ observa-
tions before and during treatment at the UDS. Clinical ex-
amination ﬁndings were based on the veterinarian’s
physical examination. Blood samples were obtained from
21 of the 28 bitches between Days –3 and 2 and in one bitch
on Days –10. In nine cases, bacterial culture results of sterile
cotton swab (Culturette, Becton–Dickinson, Stockholm,
Sweden) samples from the cranial vagina were available.
Culturing was performed at the Section of Bacteriology,
National Veterinary Institute (SVA), Uppsala, Sweden
(seven bitches); at Skövde Animal Clinic, Skövde, Sweden
(one bitch); and at Enköpings Animal Clinic, Enköping,
Sweden (one bitch). The samples were collected at the start
of aglepristone treatment (in two cases the culturing was
performed 11 and 21 days before aglepristone treatment
started). In two bitches, bacterial culture results from urine
samples were available, as performed at the National Vet-
erinary Institute (SVA), Uppsala, Sweden, and University
Animal Hospital (UDS), Uppsala, Sweden. Adverse effects
observed were based on clinical signs observed by the
veterinarian in charge at UDS and information retrieved
from the owners before and after treatment.
2.4. Statistical analysis
Successful treatment was deﬁned as return to a clini-
cally healthy status. Recurrence was deﬁned as recurrence
of the disease. Success rates and recurrence rates were
compared between younger (5 year old) and older
(>5 year old) bitches using Fisher’s exact test (Minitab 16,
Minitab Inc., State College, PA, USA). Nineteen bitches had
their ovaries evaluated by ultrasonography between Days –
10 and 16. Fisher’s exact test was used to evaluate success
rate and recovery rate between bitches with and without
cystic structures in the ovaries exceeding normal follicle
size (>1.5 cm, deﬁned as possible cyst) as detected by ul-
trasonography. Bitches evaluated as having such possible
cysts were included in the group with cysts.
3. Results
3.1. Included dogs
The 28 bitches included in the studywere of 24 different
breeds (German Shepherd dog (n ¼ 3), long-haired Collie
(n ¼ 2), English Springer Spaniel (n ¼ 2), and one each of
the following breeds: Alaskan Malamute, Australian Cat-
tledog, Australian Shepherd Dog, Bearded Collie, Boston
Terrier, Dachshund, Doberman Pinscher, Drever, Golden
Retriever, Great Dane, Irish Terrier, Irish Wolfhound, Japa-
nese Spitz, Neapolitan Mastiff, Perro de agua Espanol, Pug,
Shiba Inu, Staffordshire Bull Terrier, Standard Poodle and
Yorkshire Terrier) and one bitch of mixed breed. The age
range was 1 to 14 years when treatment started (mean age
Table 1
Case history data and clinical examination ﬁndings of the 28 bitches with
pyometra included in the study.
History data/examination ﬁnding In number
of bitches/total
number with
data available
Percentage (%)
General condition
Good 18/28 64
Moderately depressed 10/28 36
Severely depressed 0/28 0
Inappetence 13/26 50
Polyuria 7/18 39
Polydipsia 8/25 32
Vomiting 6/22 27
Diarrhea 3/22 14
Body temperature 39 C 10/24 42
Dehydration 7/14 50
Abdominal pain 10/21 48
Mildly hyperemic
mucus membranes
2/25 8
WBC over reference range 7/19 37
Increased or
decreased neutrophil numbers
11/19 58
WBC, total white blood cell count.
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(mean weight SD: 23.0  16.0 kg).
The diagnosis was based on the history, clinical exami-
nation, and laboratory ﬁndings. Abnormal vaginal
discharge in combination with a ﬂuid-ﬁlled uterus identi-
ﬁed by ultrasonography and/or radiography was present in
all, except in one case. In this case, the diagnosis was based
merely on clinical signs and physical examination ﬁndings,
and the ﬁrst ultrasonographic examination performed
10 days after treatment had been started.
Not all treatments were completed at UDS, and when
necessary, data regarding aglepristone injections, labora-
tory analyses, ultrasonography, radiography, antimicrobial
treatments, and bacterial culturing were obtained from
other veterinary clinics. Similarly, information about any
surgical treatment, previous uterine disease, and recur-
rence of pyometra after treatment were as far as possible
also obtained from other veterinary clinics and veriﬁed
through journal copies.
3.2. Treatment protocols
The bitches had been treated with aglepristone (Alizin
vet, Virbac, Stockholm, Sweden) (30 mg/mL) at a dose of
10 mg/kg sc in combination with administration of anti-
microbials during the entire treatment period in all ani-
mals, except in two. In these two bitches, the antimicrobials
were discontinued earlier than the aglepristone treatment).
Aglepristone was administered on Days 1 and 2 and
thereafter on Days 7 to 8, Days 14 to 15, and every 7th to 8th
day until the end of treatment. Antimicrobial drugs
administered to bitches in the study were enroﬂoxacin,
amoxicillin, amoxicillin/clavulanic acid, ampicillin, marbo-
ﬂoxacin, trimetoprim/sulfadiazine, and metronidazol at
doses according to Swedish guidelines (Fass vet, Läke-
medelsindustriföreningens Service, Sweden). The duration
of clinical signs before the start of treatment varied be-
tween 1 and 49 days. In 21/28 bitches, that is, 75%, treat-
ment had startedwithin 7 days after clinical signswere ﬁrst
observed (mean duration  SD: 7.8  10.4 days). In one
bitch, no information on duration of clinical signs before
diagnosis was available. Each bitch received between two
and ﬁve aglepristone injections, with a median of four in-
jections (in 12/26 bitches). Of the ﬁve bitches that had two
injections, three were admitted to surgery (ovariohyster-
ectomy) 7 days after the treatment was initiated and
received no injections after that. Data on the total number
of injections administered were missing in two bitches.
These two bitches continued the treatment at another
veterinary clinic according to the owner, and it was not
possible to retrieve these data from these clinics.
3.3. Clinical signs
All 28 bitches had visible vaginal discharge before
treatment with aglepristone started, that is, open cervix
pyometra. One bitch showed clinical signs of pyometra
7 weeks after whelping. Of the bitches, six had been mated
before they developed clinical signs of the disease. Addi-
tional case history and clinical ﬁndings are presented in
Table 1.3.4. Bacterial culture results and antimicrobial drugs
The bacteria isolated in 11 sampled bitches were E. coli
(n ¼ 6), Staphylococcus intermedius (n ¼ 2), b-hemolytic
Streptococcus (n¼2), Pseudomonas aeruginosa (n¼1), and E.
fergusonii (n ¼ 1). In one bitch, the vaginal culture was
negative. Twodifferent bacteriawere isolated in twobitches
(E. coli plus E. fergusonii and b-hemolytic Streptococcus sp.
plus Pseudomonas aeruginosa). In the bitchwith no bacterial
growth, treatment with antimicrobials was done one day
before the sample was taken. The two bitches that had
cultures from urinary samples were the bitch with negative
culture and the other with Staphylococcus intermedius.
The antimicrobial drugs that were used are listed in
Table 2. The duration of antimicrobial treatment after
aglepristone treatment started was up to 53 days with a
mean duration SD of 23  11.4 days. Eleven of the bitches
had received antimicrobial drugs 1 to 30 days before
aglepristone treatment started. The most frequently used
antimicrobial drug was enroﬂoxacin in 23 of the 28 bitches.
3.5. Successful treatment
In 75% (21/28) of the bitches, treatment was successful,
deﬁned as return to a clinically healthy status. Of the seven
bitches that did not have a successful treatment, six were
ovariohysterectomized and one was euthanized. The suc-
cess rate did not differ signiﬁcantly between young
(5 years) and older (>5 years) bitches (82% vs. 64%,
P ¼ 0.4). Presence of ovarian cystic structures larger than
follicles did not signiﬁcantly affect the success rate; 67% for
those with cystic structures and 100% for those without
cystic structures, (P ¼ 0.09).
3.6. Recurrence
Recurrence was observed in 48% (10/21) of the suc-
cessfully treated bitches, that is, recurrence only possible
Table 2
Treatments and outcome for 28 bitches diagnosed with pyometra.
ID Age (y) Days with
clinical signs
before
treatment
Number of treatments
with aglepristone
(on day)
Antimicrobial
drugs
Duration of
antimicrobial
treatment
(days)
Successful
treatment
Recurrence Time before
recurrence (mo)
Follow-up time At the end
of the
follow-up
time
1 2,7 1 2 (Days 1, 2) E 7 No d 6 d OHE
2 1 13 5 (Days 1, 2, 8, 15, 27) Amox, T 40 Yes Yes First 3.5,
second 17
2 y Intact
3 1,2 1 4 (Days 1, 2, 7, 14) Amp, E 21 Yes No 1 y, 6.5 m Intact
4 7,3 2 2 (Days 1, 2) E 13 No d 12 d OHE
5 6,6 3 4 (Days 1, 2, 10, 17) Amox 8 Yes Yes First 11,
second 18
1 y, 7 m OHE
6 13,8 2 4 (Days 1, 2, 8, 16) E 22 Yes Yes 16 1 y, 4 m Deade
7 14,1 24 4 (Days 1, 2, 9, 16) T 20 No d 23 d Deadf
8 6,2 49 3 (Days 1, 2, 9) E, Amox 22 Yes No 3 y, 8 m Intact
9 1,6 21 4 (Days 1, 2, MD, 16) E 22 Yes No 6 y Intact
10 10,4 <7 4 (Days 1, 2, 9, 16) Amp, E 18–21 Yes Yes 9,5 9.5 m Deadg
11 6,8 1 4 (Days 1, 2, 9, 18) Amox 10b No d 1 m OHE
12 3,4 1 3 (Days 1, 2, 8) E 20 Yes Yes 21 1 y, 10 m OHE
13 1,4 1 5 (Days 1, 2, 9, 16, 23) E 30 Yes No 6 y Intact
14 4,8 <7 3 (Days 1, 2, 9) E 23 Yes Yes First MD,
second 72
6 y Deadh
15 4,7 2 4 (Days 1, 2, 8, 15) E 21 Yes No 2 m Deadi
16 3,1 1 2 (Days 1, 2) E 8 No d 1 w OHE
17 4,9 Nonea MD (Days 1, 2, MD) E, M 15c Yes Yes 17,5 1 y, 6 m OHE
18 3,3 2,5 3 (Days 1, 2, 12) E, Amox 33 Yes No 3 y, 3 m to 4 y, 3 m Deadi
19 4,4 14a 3 (Days 1, 2, 8) E 22 Yes No 3 y, 1 m to 5 y, 1 m Deadi
20 3,8 1 2 (Days 1, 2) Amox 4 No d 4 d OHE
21 1,2 <7 4 (Days 1, 2, 9, 20) E 36 Yes No 4 y, 6.5 m Intact
22 2,8 10 5 (Days 1, 2, 8, 15, 28) E 33 Yes No 2 y, 7.5 m Intact
23 2,3 <7 4 (Days 1, 2, 8, 15) E 29 Yes No 4 y, 7.5 m Intact
24 9,4 7 4 (Days 1, 2, 10, 23) E 36 Yes Yes 4 5 m Deadj
25 11,4 7 MD (Days 1, 2, MD) E 11c Yes Yes 9 11 m Deadk
26 10,3 7 4 (Days 1, 2, 8, 15) E 21 Yes Yes 3 4 m OHE
27 5 1 2 (Day 1.2) E, T 33d Yes No 1 y OHE
28 6,2 18 3 (Days 1, 2, 8) Amox, E 53 No d <2 m OHE
Abbreviations: Amox ¼ Amoxicillin; Amp, Ampicillin; E, Enroﬂoxacin; M, Marboﬂoxacin; MD, missing data; OHE, ovariohysterectomy; T, trimetoprim/
sulfadiazine.
a Not so many clinical signs had ultrasonography performed for pregnancy control and a ﬂuid-ﬁlled uterus was demonstrated.
b Treatment with antimicrobial drugs started 18 d after aglepristone treatment because of mastitis. During the month before the pyometra the bitch had
been treated with antimicrobial drugs for about 3 wk.
c MD on exact time of treatment.
d Was ﬁrst treated with antimicrobial drugs for 21 d, then had a bacterial culture and after 13 days started treatment with the other antimicrobial drug
mentioned for 12 d.
e Did not respond to treatment, also had other diseases, and was euthanized.
f Did not respond to treatment and was euthanized.
g Recurrence with severely affected general condition, was not a good candidate for surgery, and was euthanized.
h Euthanized because of having a second recurrence.
i Euthanized because of other diseases.
j MD about the reason.
k Recurrence that did not respond to treatment with Cabergoline and was euthanized.
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was signiﬁcantly higher in older (>5 years) than younger
(5 years) bitches (86% vs. 29%, P ¼ 0.02). The ﬁrst
recurrence after treatment occurred from 3 to 21 months
(mean 10.5 months SD 6.5) after the end of treatment. In
one bitch, information about the exact time of recurrence
was not available. Seven bitches were either ovar-
iohysterectomized or euthanized within 2 months
because of the recurrence or other reasons. The remaining
three bitches had a second recurrence 17 to 72 months
after the ﬁrst treatment had ended. Presence of ovarian
cystic structures did not affect the recurrence rate (50%
with cystic structures and 50% without cystic structures,
P ¼ 1).3.7. Outcome
The follow-uptimewasbetween4days and6years.At the
end of the study, eight of the 28 bitches remained intact, 11
bitches had been ovariohysterectomized, and nine had died.
For thebitches thatwere still intactat theendof thestudy, the
follow-up time varied from 1.5 years to 6 years (mean  SD
follow-up time for the intact bitches was 46.5 21months).
More details about the outcome are given in Table 2.
3.8. Puppies and mating
Before the pyometra diagnosis, 21% (6/28) of the bitches
had produced at least one litter. Two of the bitches had
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getting pregnant at some point before the pyometra and six
of these had been mated 14 to 45 days before pyometra
developed. After treatment, 69% (9/13) of themated bitches
whelped and produced puppies. Of the nine bitches that
whelped, four produced one litter, four produced two lit-
ters, and one produced four litters.
3.9. Adverse effects
Adverse effects after aglepristone administration were
observed in ﬁve bitches. The adverse effects were anxiety
(three bitches) and loss of appetite (two bitches). The three
anxious bitches also showed one or more of the following
adverse effects: panting (n ¼ 2), diarrhea (n ¼ 2), abdom-
inal cramps (n ¼ 1), or polydipsia (n ¼ 1). Data were
missing in two cases. Owners of 23 bitches could not recall
any adverse effects from the treatment, but in two of these
bitches, adverse effects had been recorded in the journals,
and were thus included in the results.
4. Discussion
The overall success rate of medical treatment with
aglepristone for pyometra was 75% (21/28 bitches), deﬁned
as return to a clinically healthy status. This proportion is
somewhat lower than that reported in three other studies
of medical treatment with aglepristone where the success
rates were 100% (24/24), 83% (34/41), and 92% (48/52),
respectively [13,16,18]. Our success rate, however, was
higher than that in one report, 60% (12/20) [19]. These
differences between studies may be explained by different
selection of candidates for medical treatment because of
different traditions and routines in different countries.
Additionally, the individual patients included inﬂuence the
results, that is, minor studies may not represent the situ-
ation at large because of few included bitches. In our study,
some bitches had shown clinical signs weeks before the
treatment was initiated, which may have negatively inﬂu-
enced the outcome rather than if treatment had been
started earlier in the development of the disease. Early
treatment could be expected to give better treatment re-
sults because the uterus has been exposed to infection for a
shorter time. Generalized inﬂammation or sepsis would
then less be likely to affect the bitch systemically and with
complications less prone to occur.
All treated bitches in this study had open cervix pyo-
metra. Open cervix as opposed to closed cervix was not
reported to affect the treatment results in two studies
including both opened and closed cervix pyometra patients
[13,17]. However, another study [16] found a higher success
rate in bitches with open (85%) comparedwith closed (75%)
pyometra.
The recurrence rate in this studywas 48%, with a follow-
up time of up to 6 years. In one long-term study, the
recurrence rate was reported to be 27% within 1 year after
treatment [18]. In another study, the recurrence rate was
30% in bitches older than 5 years as evaluated by the
following estrus, and there was no recurrence in bitches
that were 5 years or younger at the start of treatment [13].
The relatively higher recurrence rate in the present studycould be due to the longer follow-up time (up to 6 years
when compared with 1 year or the next estrus) [13,18]. The
mean time until recurrence in this study was 10.5 months
and therefore it can be assumed that more bitches would
have had a recurrence recorded if they had been followed
up for a longer period of time also in the other studies. The
recurrence rate in this study estimates the actual long-term
recurrence rate, which is advantageous compared with
studies evaluating shorter time-periods after treatment.
Because the long-term recurrence rate of medical treat-
ment for pyometrawas signiﬁcantly higher in older bitches,
owners should be informed that the risk of recurrence can
be as high as 86% in bitches older than 5 years.
In three bitches, a second recurrence was observed
within 17 to 72 months after the ﬁrst pyometra treatment.
Although only three bitches with repeated recurrence were
studied, the prognosis for medical treatment of recurring
pyometra was therefore deemed poor because the disease
recurred again in all of these bitches. All the other seven
bitches that had a recurrence were either ovariohysterec-
tomized or euthanized within 2 months because of the
recurrence or for other reasons.
Six of the bitches in this study had been mated before
developing pyometra. This could be because many of the
bitches selected for medical treatment were destined for
breeding. It is unlikely that mating itself had induced
pyometra in these bitches because experimental attempts
to induce the disease by inserting bacteria in a healthy
uterus during estrus have failed [20]. In this study, 69% (9/
13) of the bitches became pregnant and whelped after
treatment. By contrast, in an earlier study, 57% (8/14) of
bitches less than 5 years old whelped and 0% (0/9) bitches
over 5 years of age [13]. Our results can also be compared
with other studies in which bitches treated with prosta-
glandin conceived in 5 out of 9 (56%) [21], 9 out of 11 (82%)
[22], 9 out of 14 (64%) [11], and 5 out of 5 (100%) [23] of the
treated cases. In one study of bitches treated with caber-
goline in combination with cloprostenol, 7 out of 11 mated
bitches (64%) produced puppies [24]. Compared with re-
sults in other studies, the fertility after mating was more
favorable in the present study. Only two bitches in this
study that were 5 years old or older when treatment star-
ted subsequently were mated; therefore, fertility after
treatment was not compared between bitches older or
younger than 5 years.
The mean duration of antimicrobial treatment was
23 days, which is longer than in some other studies (only
up to 7 days) [13,19]. The duration of antimicrobial treat-
ment was not deﬁned in some studies, which makes it
difﬁcult to compare different results in relation to antimi-
crobial treatment [16,18]. This raises the matter of whether
the antimicrobial therapy is aimed at treating the uterine
infection or to prevent progression of the infection to sepsis
and the duration of antimicrobial therapy necessary in both
situations. Possibly the progesterone antagonist is most
useful in curing the disease, and antimicrobial therapy may
be limited to fewer days than what is currently recom-
mended. Possibly the progesterone antagonist is most
useful in curing the disease, and antimicrobial therapy
could be limited to fewer days than what is currently rec-
ommended. Further studies of this aspect are needed,
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crobial resistant bacteria. The optimal duration of antimi-
crobial therapy should be studied more considering that
one of the bitches in the present study was treated for as
long as 53 days with antimicrobials.
Because this study was retrospective, it has some limi-
tations. For example, information may have been forgotten
by the owners, ultrasound examinations were not per-
formed at the same day on all bitches, and blood samples
were not obtained from all bitches. One factor that makes it
more difﬁcult to compare different studies of medical
treatment of pyometra are the different deﬁnitions
of success used and how a favorable outcome is deﬁn-
eddwhether it is return to a clinically healthy status or the
ability to produce puppies or the absence of recurrence. In
the present study, the deﬁnition of successful treatment
was a healthy status after treatment because this is some-
times the only goal when selecting medical treatment and
it is a necessity for breeding the bitch again. As a conse-
quence of being a long-term study, the number of variables
investigated produced a lot of data in fewer and fewer
bitches as the study period progressed, and a larger ma-
terial would have been desirable. However, the main
strengthwas that all included bitcheswere studied in detail
and for a substantial follow-up time.
In conclusion, if the ownerwants to breed the bitch or to
avoid surgery or anesthetics in high-risk patients, treat-
ment with aglepristone can be a good option because it was
successful in 75% of the treated bitches. However, the
possibly increased risk of offspring developing pyometra
should be considered because large breed variations in the
incidence of pyometra have been shown, which indicates
that there may be genetic factors predisposing for the
disease [1]. The owners should also be informed that the
risk of recurrence is higher for a bitch that is 5 years or
older than a younger bitch. Treatment with aglepristone
after recurrence was not successful in the present study.
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